BNF:

Not listed

Status:

Grey - after consultant/specialist initiation

Decision Date:

March 2017

Comments

GREY after consultant/specialist initiation:

• NICE TA369 for the treatment of severe keratitis. Response to treatment should be reassessed at least every 6 months by the specialist.

Grey Drug Classifications

• 1: Lack of data on effectiveness compared with standard therapy

search again